This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Blum, A. Search for Related Content PubMed PubMed Citation Articles by Blum, A.

(Circulation. 1999;100:e138.)
© 1999 American Heart Association, Inc.

Circulation Electronic Pages

Anti-CMV Antibodies and Coronary Artery Disease

Arnon Blum, MD

Cardiology Branch National Institutes of Health, Bethesda, Md

	Introduction

 
To the Editor:

Recently, Ridker et al published their observations about cytomegalovirus (CMV) and atherosclerosis.¹ They found that "there is no evidence of a positive association between baseline IgG antibodies directed against CMV or HSV [herpes simplex virus] and the development of future MI [myocardial infarction] or thromboembolic stroke. Furthermore, we found no evidence of association between CMV or HSV exposure and concentration of CRP [C-reactive protein]".¹

I would like to mention 2 important factors that were mentioned in the article but were not evaluated carefully:

1. The IgG level was measured only at study entry, and the follow-up continued for 12 years. It is true that an antibody titer (especially IgG) does not change "quickly"; however, it is a little extreme to assume that an antibody titer does not change over 12 years!

2. I would like to refer the authors to our study that was published recently.² In this study, we wrote that "the results of our study demonstrated a similar prevalence of CMV seropositivity in patients with coronary artery disease and an age- and sex-matched control group; however, anti-CMV IgG antibody titer was higher in patients with coronary artery disease (52% of the patients had >1:800 anti CMV IgG titer, whereas only 16% of the control group had high antibody titer)."

I believe that antibody titer can differentiate between patients with coronary artery disease (high IgG titer, 1:800) and people who are seropositive (1:400) for anti-CMV IgG antibodies. The mechanism of action could be direct activation . . . [Full Text of this Article]